Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
74,190,609
-
Total 13F shares
-
29,531,130
-
Share change
-
-182,972
-
Total reported value
-
$34,268,486
-
Price per share
-
$1.16
-
Number of holders
-
75
-
Value change
-
-$243,677
-
Number of buys
-
1
-
Number of sells
-
2
Institutional Holders of ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share (ENZN) as of Q4 2013
As of 31 Dec 2013,
ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share (ENZN) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,531,130 shares.
The largest 10 holders included
ICAHN CARL C, BAUPOST GROUP LLC/MA, BlackRock Institutional Trust Company, N.A., State Street Corp, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, BlackRock Fund Advisors, BRANDES INVESTMENT PARTNERS, LP, FMR LLC, and BlackRock Advisors LLC.
This page lists
75
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.